My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Celularity Inc. - Class A Common Stock (NQ:CELU)

1.265 +0.035 (+2.85%)

Streaming Delayed Price Updated: 3:59 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Celularity Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 Next >

Why Cramer Recommends Buying Marvell Technology ↗

May 05, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Accenture plc (NYSE: ACN) had a great quarter. He recommended buying the stock.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022 ↗

April 06, 2022

Upgrades

Via Benzinga

The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business ↗

August 17, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc...

Via Benzinga

Market Briefing For Wednesday, July 21 ↗

July 21, 2021

Via Talk Markets

10 Health Care Stocks Whale Activity In Today's Session ↗

March 17, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

96 Biggest Movers From Yesterday ↗

March 15, 2022

Gainers Volt Information Sciences, Inc. (NYSE: VOLT) shares surged 94.7% to close at $5.88 on Monday after the company announced it would be acquired for $6 per share. Incannex...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

March 09, 2022

Gainers Sunshine Biopharma (NASDAQ:SBFM) stock rose 222.4% to $4.9 during Wednesday's pre-market session. The company's market cap stands at $21.9 million. TC...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 07, 2022

Gainers TherapeuticsMD (NASDAQ:TXMD) stock moved upwards by 38.1% to $0.29 during Monday's regular session. As of 12:30 EST, TherapeuticsMD's stock is trading at a...

Via Benzinga

A Peek Into The Markets: US Stock Futures Surge Amid Signs Of Easing Russia-Ukraine Tensions ↗

February 15, 2022

Pre-open movers

Via Benzinga

FDA Grants Fast Track Tags To Drug Candidates For Antares Pharma, Celcuity, Celularity ↗

January 18, 2022

The FDA has granted Fast Track designation to Antares Pharma Inc's (NASDAQ: ATRS) for ATRS-1902 for adrenal crisis rescue. The development program...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

December 28, 2021

Gainers BiondVax Pharmaceuticals (NASDAQ:BVXV) shares moved upwards by 41.2% to $3.29 during Tuesday's pre-market session. The company's market cap stands at $47.1...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 29, 2021

Gainers Krystal Biotech (NASDAQ:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 24, 2021 ↗

November 24, 2021

Upgrades For Aegon NV (NYSE:...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2021 ↗

October 19, 2021

Upgrades Maxim Group upgraded the previous rating for Indaptus Therapeutics Inc (NASDAQ:

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 22, 2021

Gainers Aethlon Medical (NASDAQ:AEMD) shares rose 33.15% to $5.06 during Wednesday's pre-market session. The market value of their outstanding shares is at $77.8...

Via Benzinga

50 Biggest Movers From Yesterday ↗

September 23, 2021

Gainers Marin Software Incorporated (NASDAQ: MRIN) shares jumped 61.9% to close at $9.21 on Wednesday following an announcement from management that the company entered into a...

Via Benzinga

Cramer Weighs In On Joby Aviation, Pitney Bowes And More ↗

September 22, 2021

On CNBC's "Mad Money Lightning Round," Jim Cramer said Celularity Inc (NASDAQ: CELU) is interesting. Nobody likes it, but if you buy it here, you might get really...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 07, 2021

Gainers Cellectar Biosciences (NASDAQ:CLRB

Via Benzinga

72 Biggest Movers From Yesterday ↗

September 08, 2021

Gainers Mechel PAO (NYSE: MTL) shares climbed 56.3% to settle at $5.00 on Tuesday. The company recently reported Q2results, including a 43% quarter-over-quarter revenue growth....

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 07, 2021

Gainers Surrozen (NASDAQ:SRZN) stock rose 33.14% to $9.64 during Tuesday's regular session. The company's market cap stands at $351.2 million. ZIOPHARM Oncology (...

Via Benzinga

14 SPACs That Palantir Technologies Has Invested In Or Partnered ↗

August 20, 2021

Palantir Technologies Inc (NYSE: PLTR) is one of the most well-known publicly traded companies. The data analytics company is increasing its investments in the SPAC space,...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 17, 2021

Gainers Celularity (NASDAQ:CELU) shares rose 7.0% to $7.33 during Tuesday's after-market session. The market value of their outstanding shares is at $904.9...

Via Benzinga

Analyzing Celularity's Unusual Options Activity ↗

July 22, 2021

Celularity (NASDAQ:CELU) shares experienced unusual options activity on Thursday. The stock price moved up to $10.34 following the option alert. Sentiment: BULLISH Option Type:...

Via Benzinga

EXCLUSIVE: Celularity's CEO On 'One-Size-Fits-All' Product, Palantir Connection ↗

July 21, 2021

Former PepsiCo Inc (NASDAQ: PEP) president and Apple Inc (NASDAQ: AAPL) CEO John Sculley raved about Celularity Inc (NASDAQ: CELU) Monday on Benzinga's YouTube...

Via Benzinga

The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO ↗

August 13, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (...

Via Benzinga

77 Biggest Movers From Yesterday ↗

August 13, 2021

Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares surged 65.4% to close at $2.10 on Thursday after the company announced it is expanding its blockchain business to...

Via Benzinga

EXCLUSIVE: Former PepsiCo President And Apple CEO John Sculley Tells A Steve Jobs Story ↗

July 19, 2021

John Sculley, former president of PepsiCo Inc (NASDAQ: PEP) and former CEO of Apple Inc (NASDAQ: AAPL), appeared on Benzinga's YouTube show "Power...

Via Benzinga

The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma ↗

August 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (...

Via Benzinga

61 Biggest Movers From Yesterday ↗

July 22, 2021

Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares surged 159.2% to close at $5.34 on Wednesday after the company received a $28.3 million purchase order from Brazil's...

Via Benzinga

54 Biggest Movers From Yesterday ↗

July 20, 2021

Gainers Aehr Test Systems (NASDAQ: AEHR) shares climbed 87.9% to close at $6.39 on Monday after the company won a $10.8 million single purchase order from its lead silicon...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.